CRISPR has been used to identify regulators that block antigen-dependent cell phagocytosis (ADCP), a process by which monoclonal antibodies target tumor antigens trigger macrophages to engulf cancer cells.[22] Thereby, specific PRs were identified using differential expression analysis by analyzing RNA-sequence data of TCGA-TC cohort. This evidence concerns the gene WNK3 and neoplasm.